MedPacto메드팩토
235980 · KOSDAQ · ₩235980 · 메드팩토
₩3,050▲ ₩80 (2.69%)End-of-day · Oct 30, 2026 · End-of-day prices.
Filings
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인) (재발성, 불응성 또는 진행성 골육종 환자 대상 백토서팁 단독 요법 제1/2상 임상시험계획(IND) 미국 식품의약국(FDA) 변경 승인)Oct 19, 2026Open on DART
Predicted impact: Medium
FDA approved change to osteosarcoma Phase 1/2 trial plan; clinical-stage biotech with tiny revenue.
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청등결정) (MP2021 호주 임상1상 시험 계획 승인)Oct 2, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인) (재발성, 불응성 또는 진행성 골육종 환자 대상 백토서팁 단독 요법 제1/2상 임상시험계획(IND) 한국 식약처(MFDS) 변경승인)Sep 18, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (재발성, 불응성 또는 진행성 골육종 환자 대상 백토서팁 단독 요법 제1/2상 임상시험계획(IND) 한국 식약처(MFDS) 변경승인신청)Sep 18, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인신청) (재발성, 불응성 또는 진행성 골육종 환자 대상 백토서팁 단독 요법 제1/2상 임상시험계획(IND) 미국 식품의약국(FDA) 변경승인신청)Sep 18, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인) (재발성, 불응성 또는 진행성 골육종 환자 대상 백토서팁 단독 요법 제1/2상 임상시험계획(IND) 한국 식약처(MFDS) 변경승인)Sep 15, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 13, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인신청) (재발성, 불응성 또는 진행성 골육종 환자 대상 백토서팁 단독 요법 제1/2상 임상시험계획(IND) 한국 식약처(MFDS) 변경승인신청)Aug 7, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Jul 24, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Jul 23, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청) (MP2021 호주 임상1상 시험 계획 승인신청)Jul 15, 2026Open on DART
- Change of CEO대표이사변경May 15, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 13, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Mar 26, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Mar 26, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Mar 26, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Mar 26, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Mar 26, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 26, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
- Audit report submitted감사보고서제출Mar 17, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 6, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 6, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 6, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 5, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 12, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 12, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Nov 11, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Jul 31, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jul 17, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과) (진행성 NSCLC를 대상으로 한 백토서팁과 더발루맙 병용요법의 제 1b/2a상, 공개시험 결과)Jun 11, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 28, 2025Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 28, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 21, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 21, 2025Open on DART
- Audit report submitted감사보고서제출Mar 20, 2025Open on DART
- Annual report (Dec 2024)사업보고서 (2024.12)Mar 20, 2025Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 13, 2025Open on DART
- Shareholders' meeting called주주총회소집결의Mar 13, 2025Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 13, 2025Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 13, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 5, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 5, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 5, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 5, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 5, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 5, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: MedPacto / 메드팩토 / 235980 / KRX:235980
Source: KRX statistical information